Identifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine.
Jones, Angus G.
Hyde, C. J.
Henley, W. E.
Hattersley, Andrew T.
Research Support, Non-U.S. Gov't
RightsArchived with thanks to PloS one
MetadataShow full item record
Defining responders to glucose lowering therapy can be important for both clinical care and for the development of a stratified approach to diabetes management. Response is commonly defined by either HbA1c change after treatment or whether a target HbA1c is achieved. We aimed to determine the extent to which the individuals identified as responders and non-responders to glucose lowering therapy, and their characteristics, depend on the response definition chosen.